Aspira Women's Health Inc.
AWHL
$0.41
-$0.01-1.58%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.13% | -0.78% | 5.85% | 10.28% | 1.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.13% | -0.78% | 5.85% | 10.28% | 1.80% |
| Cost of Revenue | 2.22% | -13.17% | -23.43% | -5.60% | -0.88% |
| Gross Profit | 2.07% | 7.95% | 28.50% | 22.15% | 3.67% |
| SG&A Expenses | -46.36% | -45.26% | -23.83% | 2.91% | -5.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.28% | -38.17% | -19.58% | -7.74% | -5.24% |
| Operating Income | 57.83% | 58.80% | 31.21% | 17.03% | 9.04% |
| Income Before Tax | -37.92% | 24.48% | 59.97% | 55.07% | 24.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -37.92% | 24.48% | 59.97% | 55.07% | 24.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.92% | 24.48% | 59.97% | 55.07% | 24.63% |
| EBIT | 57.83% | 58.80% | 31.21% | 17.03% | 9.04% |
| EBITDA | 58.91% | 58.80% | 31.06% | 16.62% | 8.71% |
| EPS Basic | 41.62% | 73.40% | 78.05% | 72.04% | 52.18% |
| Normalized Basic EPS | 41.63% | 73.38% | 78.05% | 42.75% | 52.18% |
| EPS Diluted | 41.62% | 73.40% | 78.05% | 72.04% | 52.18% |
| Normalized Diluted EPS | 41.63% | 73.38% | 78.05% | 42.75% | 52.18% |
| Average Basic Shares Outstanding | 136.20% | 184.09% | 82.26% | 60.60% | 57.58% |
| Average Diluted Shares Outstanding | 136.20% | 184.09% | 82.26% | 60.60% | 57.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |